Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia

International Journal of Gynecology and Obstetrics

Volumn 103, Issue 1, 2008, Pages 33-37

  Yarandi, Fariba ^a   Eftekhar, Zahra ^a   Shojaei, Hadi ^a   Kanani, Soheyla ^a   Sharifi, Ali ^a   Hanjani, Parviz ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

Actinomycin D; Gestational trophoblastic neoplasia; Methotrexate; Single agent chemotherapy

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; DACTINOMYCIN; METHOTREXATE;

ADULT; ALOPECIA; ANOREXIA; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; FATIGUE; FEMALE; HEMOPTYSIS; HUMAN; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NEUTROPENIA; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT RESPONSE; TROPHOBLASTIC TUMOR; TUMOR VOLUME; VAGINA BLEEDING; WORLD HEALTH ORGANIZATION;

EID: 52049088935     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2008.05.013     Document Type: Article

References (21)

1. Bower M., Newlands E.S., Holden L., Short D., Brock C., Rustin G.J., et al. EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol 15 7 (1997) 2636-2643
2. Matsui H., Suzuka K., Iitsuka Y., Seki K., and Sekiya S. Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 78 1 (2000) 28-31
3. Berkowitz R.S., Goldstein D.P., and Bernstein M.R. Ten year's experience with methotrexate and folinic acid as primary therapy for gestational trophoblastic disease. Gynecol Oncol 23 1 (1986) 111-118
4. Hoffman M.S., Fiorica J.V., Gleeson N.C., Roberts W.S., and Cavanagh D. A single institution experience with weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Gynecol Oncol 60 2 (1996) 292-294
5. Lurain J.R. Treatment of gestational trophoblastic tumors. Curr Treat Options Oncol 3 2 (2002) 113-124
6. Lurain J.R., and Nejad B. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 97 2 (2005) 618-623
7. Soper J.T., Clarke-Pearson D.L., Berchuck A., Rodriguez G., and Hammond C.B. 5-day methotrexate for women with metastatic gestational trophoblastic disease. Gynecol Oncol 54 1 (1994) 76-79
8. Bagshawe K.D. Risk and prognostic factors in trophoblastic neoplasia. Cancer 38 3 (1976) 1373-1385
9. Homesley H.D., Blessing J.A., Rettenmaier M., Capizzi R.L., Major F.J., and Twiggs L.B. Weekly intramuscular methotrexate for nonmetastatic gestational trophoblastic disease. Obstet Gynecol 72 3 Pt 1 (1988) 413-418
10. Petrilli E.S., Twiggs L.B., Blessing J.A., Teng N.H., and Curry S. Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease: a prospective phase II trial of the Gynecologic Oncology Group. Cancer 60 9 (1987) 2173-2176
11. American College of Obstetricians and Gynecologists. Management of gestational trophoblastic disease. ACOG Technical Bulletin vol. 178 (1993), American College of Obstetricians and Gynecologists, Washington, DC
12. Homesley H.D. Single-agent therapy for nonmetastatic and low-risk gestational trophoblastic disease. J Reprod Med 43 1 (1998) 69-74
13. International Federation of Gynecologists and Obstetricians; FIGO Oncology Committee. FIGO staging for gestational trophoblastic neoplasia 2000. Int J Gynecol Obstet 77 3 (2002) 285-287
14. Foulmann K., Guastalla J.P., Caminet N., Trillet-Lenoir V., Raudrant D., Golfier F., et al. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? a review of the evidence. Gynecol Oncol 102 1 (2006) 103-110
15. Ngan S., and Seckl M.J. Gestational trophoblastic neoplasia management: an update. Curr Opin Oncol 19 5 (2007) 486-491
16. Ehlen T.G., Bessette P., Gerulath A.H., Jolicoeur L., and Savoie R. Gestational trophoblastic disease: SOGC clinical practice guideline 114 (May 2002), Society of Obstetricians and Gynecologists of Canada, Ottawa, Ontario, Canada. http://www.sogc.org/guidelines/#Gynaecology http://www.sogc.org/guidelines/#Gynaecology
17. Kwon J.S., Elit L., Mazurka J., Moens F., and Schmuck M.L. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia. Gynecol Oncol 82 2 (2001) 367-370
18. McNeish I.A., Strickland S., Holden L., Rustin G.J., Foskett M., Seckl M.J., et al. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol 20 7 (2002) 1838-1844
19. Homesley R.D. Development of single-agent chemotherapy regimens for gestational trophoblastic disease. J Reprod Med 39 3 (1994) 185-192
20. Petrilli E.S., and Morrow C.P. Actinomycin D toxicity in the treatment of trophoblastic disease: a comparison of the five-day course to single-dose administration. Gynecol Oncol 9 1 (1980) 18-22
21. Ross G.T., Stolbach L.L., and Hertz R. Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. Cancer Res 22 (1962) 1015-1017